Fundraising Fox

Kris Verburgh

Investor

Partner BOLD Longevity at Bold Capital Partners

London, England, United Kingdom

About

Kris Verburgh is a medical doctor and Partner and Head of Science at the BOLD Longevity Growth Fund, which invests in biotechnologies aimed at slowing aging. He previously held the same role at the Longevity Vision Fund, a $100 million fund that has since closed to new investments, and co-founded NOVOS, a nutraceutical targeting nine hallmarks of aging. He has written four books, including "The Longevity Code," which addresses nutrition and biotechnology in relation to aging and health.

Experience

  1. BOLD Longevity Growth FundPartner & Head of Sciencecurrent2023 — presentBoston, Massachusetts, United States
  2. Singularity UniversityExpert - Medicine, Biotech and Longevitycurrent2016 — present
  3. Vrije Universiteit BrusselScientific Researcher - Future of Medicine and Longevitycurrent2014 — present
  4. Vrije Universiteit BrusselMember Evolution, Complexity and Cognition Group (ECCO)current2014 — present
  5. Consultations & Longevity Concierge ServicesMedical doctor (MD)current2011 — present
  6. Speakers Academy®Speaker / Panelistcurrent2004 — present
  7. HarperCollins Publishers & PrometheusAuthorcurrent2003 — presentLondon - New York
  8. Longevity Vision FundPartner & Head of Science2019 — 2023New York, United States
  9. NOVOSCo-Founder2019 — 2023New York, United States
  10. Voeding LeeftMember Advisory Board 'Voeding Leeft'​ ('Nutrition Lives'​)2015 — 2018

Skills & more

Public Speaking14Management1Medicine19Metabolism2Biotechnology9Science42Lifesciences9Neuroscience35Research27Statistics3Molecular Biology5Preventive Medicine6
+12 moreEntrepreneurshipBloggingTeachingNutritionCancerNeurologyCell BiologyCoachingBusiness StrategyLife SciencesEnglishInnovation

Languages Dutch · English · French · German · Spanish

From Kris's professional profile.

Colleagues at Bold Capital Partners

Frequently asked questions

Who is Kris Verburgh?
Kris Verburgh is a medical doctor and Partner and Head of Science at the BOLD Longevity Growth Fund, which invests in biotechnologies aimed at slowing aging. He previously held the same role at the Longevity Vision Fund, a $100 million fund that has since closed to new investments, and co-founded NOVOS, a nutraceutical targeting nine hallmarks of aging. He has written four books, including "The Longevity Code," which addresses nutrition and biotechnology in relation to aging and health.
Where does Kris Verburgh work?
Kris Verburgh is Partner BOLD Longevity at Bold Capital Partners.
Where did Kris Verburgh go to school?
Kris Verburgh studied at Vrije Universiteit Brussel (Research (new developments in medicine, biotechnology and longevity)); University of Antwerp (Medicine); Sint-Jan Berchmans Institute (Science and mathematics).

Same school

Shared employers

Also worked at Singularity University50

+ 44 more

Also worked at Vrije Universiteit Brussel9

+ 3 more

Also worked at HarperCollins Publishers & Prometheus8

+ 2 more

Also worked at Longevity Vision Fund7

+ 1 more